• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical Characteristics, Microbiological and Risk Factors of Infections in Patients With Systemic Lupus Erythematosus.系统性红斑狼疮患者感染的临床特征、微生物学及危险因素
J Community Hosp Intern Med Perspect. 2025 Jan 6;15(1):36-41. doi: 10.55729/2000-9666.1447. eCollection 2025.
2
Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials.生物制剂治疗系统性红斑狼疮或活动性狼疮肾炎及感染并发症发生率。来自大型临床试验的证据。
Front Immunol. 2022 Sep 23;13:999704. doi: 10.3389/fimmu.2022.999704. eCollection 2022.
3
Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.患有系统性红斑狼疮的菲律宾人中带状疱疹感染的风险因素。
Int J Rheum Dis. 2020 Feb;23(2):197-202. doi: 10.1111/1756-185X.13725. Epub 2019 Nov 6.
4
Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.阿尼鲁单抗用于狼疮的干扰素抑制:对导致美国食品药品监督管理局批准的证据的批判性评估。
ACR Open Rheumatol. 2022 Jun;4(6):486-491. doi: 10.1002/acr2.11414. Epub 2022 Feb 14.
5
Short-term prognostic analysis of patients with systemic lupus erythematosus co-infection and comparison of mNGS and conventional microbiological test results.系统性红斑狼疮合并感染患者的短期预后分析及 mNGS 与传统微生物学检测结果比较
Front Cell Infect Microbiol. 2023 Mar 27;13:1131258. doi: 10.3389/fcimb.2023.1131258. eCollection 2023.
6
Severe pneumonia in Chinese patients with systemic lupus erythematosus.中国系统性红斑狼疮患者的严重肺炎。
Lupus. 2020 Jun;29(7):735-742. doi: 10.1177/0961203320922609. Epub 2020 May 13.
7
Predisposing Factors of Tuberculosis Infection in Systemic Lupus Erythematosus Patients: A Single-Center Case-Control Study.系统性红斑狼疮患者结核感染的易感因素:一项单中心病例对照研究
Cureus. 2022 Jun 28;14(6):e26410. doi: 10.7759/cureus.26410. eCollection 2022 Jun.
8
Clinical characteristics and risk factors of infection in patients with systemic lupus erythematosus: A systematic review and meta-analysis of observational studies.系统性红斑狼疮患者感染的临床特征和危险因素:一项观察性研究的系统回顾和荟萃分析。
Semin Arthritis Rheum. 2020 Oct;50(5):1022-1039. doi: 10.1016/j.semarthrit.2020.06.004. Epub 2020 Jun 17.
9
Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.新诊断的西班牙系统性红斑狼疮患者的感染情况:来自RELES队列的数据。
Lupus. 2018 Dec;27(14):2253-2261. doi: 10.1177/0961203318811598.
10
Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.系统性红斑狼疮缓解和低疾病活动状态的预测因素:来自多民族、多国拉丁美洲队列的数据。
J Rheumatol. 2019 Oct;46(10):1299-1308. doi: 10.3899/jrheum.180433. Epub 2019 Mar 1.

本文引用的文献

1
Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids.系统性红斑狼疮患者长期暴露于中高剂量糖皮质激素下发生血流感染的风险
Lupus. 2023 Apr;32(5):625-632. doi: 10.1177/09612033231160731. Epub 2023 Mar 1.
2
Herpes zoster in SLE: prevalence, incidence and risk factors.红斑狼疮合并带状疱疹:患病率、发病率及危险因素。
Lupus Sci Med. 2022 Jan;9(1). doi: 10.1136/lupus-2021-000574.
3
Culture-independent detection systems for bloodstream infection.用于血流感染的非培养检测系统。
Clin Microbiol Infect. 2022 Feb;28(2):195-201. doi: 10.1016/j.cmi.2021.09.039. Epub 2021 Oct 20.
4
Clinical Application of Chinese Herbal Injection for Cancer Care: Evidence-Mapping of the Systematic Reviews, Meta-analyses, and Randomized Controlled Trials.中药注射剂在癌症护理中的临床应用:系统评价、Meta分析和随机对照试验的证据图谱
Front Pharmacol. 2021 May 7;12:666368. doi: 10.3389/fphar.2021.666368. eCollection 2021.
5
Systemic lupus erythematosus and infections.系统性红斑狼疮与感染。
Reumatismo. 2020 Nov 19;72(3):154-169. doi: 10.4081/reumatismo.2020.1303.
6
Hospitalized Infections in Lupus: A Nationwide Study of Types of Infections, Time Trends, Health Care Utilization, and In-Hospital Mortality.狼疮患者的院内感染:一项全国范围内的感染类型、时间趋势、医疗利用和住院死亡率研究。
Arthritis Rheumatol. 2021 Apr;73(4):617-630. doi: 10.1002/art.41577. Epub 2021 Mar 5.
7
The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis.成人系统性红斑狼疮患者感染风险:系统评价和荟萃分析。
Rheumatology (Oxford). 2021 Jan 5;60(1):60-72. doi: 10.1093/rheumatology/keaa478.
8
Infections in Systemic Lupus Erythematosus.系统性红斑狼疮中的感染
J Assoc Physicians India. 2020 May;68(5):18-21.
9
Systemic lupus erythematosus and risk of infection.系统性红斑狼疮与感染风险。
Expert Rev Clin Immunol. 2020 May;16(5):527-538. doi: 10.1080/1744666X.2020.1763793. Epub 2020 Jun 1.
10
Harmful effects of high amounts of glucose on the immune system: An updated review.高浓度葡萄糖对免疫系统的有害影响:最新综述。
Biotechnol Appl Biochem. 2021 Apr;68(2):404-410. doi: 10.1002/bab.1938. Epub 2020 Jun 8.

系统性红斑狼疮患者感染的临床特征、微生物学及危险因素

Clinical Characteristics, Microbiological and Risk Factors of Infections in Patients With Systemic Lupus Erythematosus.

作者信息

Li Guanhua, Liu Xiaojing, Zhao Jiakang

机构信息

Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

出版信息

J Community Hosp Intern Med Perspect. 2025 Jan 6;15(1):36-41. doi: 10.55729/2000-9666.1447. eCollection 2025.

DOI:10.55729/2000-9666.1447
PMID:39867159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11759075/
Abstract

OBJECTIVE

To determine risk factors, clinical and microbiological characteristics of infections in a single-center systemic lupus erythematosus (SLE) cohort.

METHODS

All hospital patients in The First Affiliated Hospital of Zhengzhou University from 2019 to 2021 who meet ≥4 ACR-97 SLE criteria were identified. Patients with infection and without infection were included with a ratio of 1:2.

RESULTS

687 SLE patients were identified and 224 patients with infection and 448 patients without infection were included. The most common microorganisms in the infection group were , Herpes zoster and Aspergillus, respectively. In the cox regression analysis, nephritis (OR 1.785; 95% CI: 1.156-2.756), diabetes(OR 6.507; 95% CI: 2.692-15.725), CD4+ T cell (OR 1.003; 95% CI: 1.002-1.004), prednisone>10 mg/day (OR 1.879; 95% CI: 1.112-3.175), immunosuppressants (OR 0.465; 95% CI: 0.310-0.697) and SLEDAI score (OR 0.866; 95% CI: 0.837-0.896) were risk factors associated with infection.

CONCLUSIONS

Bacteria was the most common infection in SLE patients with the respiratory tract being the most common site. Nephritis, diabetes, SLEDAI score were associated with infection. Monitoring CD4+ T cell can predict the infection incidence. Prednisone (>10 mg/day) and immunosuppressants increase the occurrence of infection.

摘要

目的

确定单中心系统性红斑狼疮(SLE)队列中感染的危险因素、临床及微生物学特征。

方法

识别出郑州大学第一附属医院2019年至2021年期间符合≥4条美国风湿病学会(ACR)1997年SLE标准的所有住院患者。感染患者与未感染患者按1:2的比例纳入。

结果

共识别出687例SLE患者,其中224例感染患者和448例未感染患者被纳入研究。感染组最常见的微生物分别为 、带状疱疹和曲霉菌。在Cox回归分析中,肾炎(比值比[OR]1.785;95%置信区间[CI]:1.156 - 2.756)、糖尿病(OR 6.507;95% CI:2.692 - 15.725)、CD4 + T细胞(OR 1.003;95% CI:1.002 - 1.004)、泼尼松>10 mg/天(OR 1.879;95% CI:1.112 - 3.175)、免疫抑制剂(OR 0.465;95% CI:0.310 - 0.697)和SLE疾病活动指数(SLEDAI)评分(OR 0.866;95% CI:0.837 - 0.896)是与感染相关的危险因素。

结论

细菌是SLE患者中最常见的感染病原体,呼吸道是最常见的感染部位。肾炎、糖尿病、SLEDAI评分与感染相关。监测CD4 + T细胞可预测感染发生率。泼尼松(>10 mg/天)和免疫抑制剂会增加感染的发生。